| Date Filed | Type | Description |
| 09/28/2023 |
4
| Connealy Pamela Ann (CFO and COO) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Bought 8,000 shares
@ $1.87, valued at
$15k
|
|
| 09/27/2023 |
4
| Connealy Pamela Ann (CFO and COO) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Bought 6,426 shares
@ $1.8468, valued at
$11.9k
|
|
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2023 |
4/A
| Connealy Pamela Ann (Director) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Granted 23,250 options to buy
@ $10, valued at
$232.5k
|
|
| 05/05/2023 |
4
| Yanchik Connealy Pamela (Director) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Exercised 758 options to buy
@ $0 |
|
| 05/05/2023 |
4/A
| Yanchik Connealy Pamela (Director) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Granted 1,516 options to buy
@ $0 |
|
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2023 |
4
| Yanchik Connealy Pamela (Director) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Granted 3,488 shares
@ $0
Granted 18,600 options to buy
@ $7.66, valued at
$142.5k
Granted 23,250 options to buy
@ $10, valued at
$232.5k
|
|
| 01/30/2023 |
3
| Yanchik Connealy Pamela (Director) has filed a Form 3 on Orchestra BioMed Holdings, Inc. |
| 01/03/2023 |
4
| Yanchik Connealy Pamela (CFO) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 43,493 shares
@ $0 |
|
| 04/15/2022 |
4
| Yanchik Connealy Pamela (CFO) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 93,493 shares
@ $0 |
|
| 04/04/2022 |
4
| Yanchik Connealy Pamela (CFO) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 247,524 shares
@ $0 |
|
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2021 |
3
| Yanchik Connealy Pamela (CFO) has filed a Form 3 on Pyxis Oncology, Inc. |
| 03/23/2021 |
4
| Yanchik Connealy Pamela (CFO) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 46,200 shares
@ $0
Granted 162,000 options to buy
@ $17, valued at
$2.8M
|
|
| 05/18/2020 |
4
| Yanchik Connealy Pamela (CFO) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 180,500 options to buy
@ $19.01, valued at
$3.4M
|
|
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |